IL-12p35 single chain subunit antagonizes IL-6 mediated STAT1 and STAT3 activation and prevents expansion of Th17 cells in experimental autoimmune uveitis (CCR1P.246)
| Autor: | Ivy Dambuza, Cheng-Rong Yu, Ren-Xi Wang, Sung-Ye Kim, Rashid Mahdi, Monika Dolinska, Yuri Sergeev, Paul Wingfield, Charles Egwuagu |
|---|---|
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | The Journal of Immunology. 192:48.6-48.6 |
| ISSN: | 1550-6606 0022-1767 |
| DOI: | 10.4049/jimmunol.192.supp.48.6 |
| Popis: | The Interleukin 12 (IL-12) family of cytokines is comprised of heterodimeric proteins including IL-12 (p35/p40), IL-23 (p19/p40), IL-27 (IL27p28/Ebi3) and IL-35 (p35/Ebi3). IL-27p28 and IL-12p40 have recently been shown to antagonize IL-27 and IL-12 functions, respectively, suggesting that single chain IL-12 family members may act as dominant-negative inhibitors of IL-12 family heterodimeric cytokines. Here, we have genetically engineered IL-12p35 (rIL-12p35) and examined whether IL-12p35 has biological activities independent of its partner, IL-12p40 or EBI3. We show that rIL-12p35 blocked IL-6 mediated activation of STAT1 and STAT3 pathways of TCR-activated CD4+ T cells and inhibited the expansion of Th17 but not Th1 cells. Of particular significance, rIL-12p35 protected mice from autoimmune uveitis by inhibiting pathogenic Th17 cell expansion. Our study demonstrates that IL-12p35 can be used to modulate IL-6-mediated signaling pathways and treat a CNS autoimmune disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|